Literature DB >> 31833412

Polyvascular Disease: Reappraisal of the Current Clinical Landscape.

J Antonio Gutierrez1, Aaron W Aday2, Manesh R Patel1, W Schuyler Jones1.   

Abstract

Atherosclerosis within 2 or more arterial beds has been termed polyvascular disease. Although polyvascular disease has long been associated with heightened cardiovascular risk, much is still unknown regarding its pathophysiology and management. In this past decade, the field of cardiovascular disease has experienced exponential growth in terms of antithrombotic and lipid-lowering therapies aimed at mitigating ischemic events. This review describes the inherent risk associated with polyvascular disease in contemporary observational and clinical trial populations and summarizes novel therapies in this high-risk population.

Entities:  

Keywords:  atherosclerosis; cardiovascular diseases; lipids; myocardial infarction; stroke

Mesh：

Year:  2019        PMID： 31833412      PMCID： PMC7660526          DOI： 10.1161/CIRCINTERVENTIONS.119.007385

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


  28 in total

1.  Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.

Authors:  Aruna D Pradhan; Sanjay Shrivastava; Nancy R Cook; Nader Rifai; Mark A Creager; Paul M Ridker
Journal:  Circulation       Date:  2008-01-28       Impact factor: 29.690

2.  The prevalence of polyvascular disease in patients referred for peripheral arterial disease.

Authors:  R Vidakovic; O Schouten; R Kuiper; S E Hoeks; W-J Flu; J P van Kuijk; D Goei; H J M Verhagen; A N Neskovic; D Poldermans
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-06-27       Impact factor: 7.069

Review 3.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

Review 4.  Epidemiology of peripheral artery disease.

Authors:  Michael H Criqui; Victor Aboyans
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

5.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

6.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Authors:  Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-03-01       Impact factor: 29.983

Review 7.  Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies.

Authors:  Jack Hirsh; Deepak L Bhatt
Journal:  Arch Intern Med       Date:  2004-10-25

8.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Authors:  Marc S Sabatine; Robert P Giugliano; Anthony C Keech; Narimon Honarpour; Stephen D Wiviott; Sabina A Murphy; Julia F Kuder; Huei Wang; Thomas Liu; Scott M Wasserman; Peter S Sever; Terje R Pedersen
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

9.  Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.

Authors:  Claes Held; Harvey D White; Ralph A H Stewart; Andrzej Budaj; Christopher P Cannon; Judith S Hochman; Wolfgang Koenig; Agneta Siegbahn; Philippe Gabriel Steg; Joseph Soffer; W Douglas Weaver; Ollie Östlund; Lars Wallentin
Journal:  J Am Heart Assoc       Date:  2017-10-24       Impact factor: 5.501

Review 10.  PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.

Authors:  Seth J Baum; Peter P Toth; James A Underberg; Paul Jellinger; Joyce Ross; Katherine Wilemon
Journal:  Clin Cardiol       Date:  2017-03-22       Impact factor: 2.882
View more
  13 in total

1.  Symptom Progression in Peripheral Artery Disease: Sounding the Alarm for Cardiovascular Risk.

Authors:  Tara A Holder; Aaron W Aday
Journal:  Circ Cardiovasc Interv       Date:  2020-10-12       Impact factor: 6.546

Review 2.  Medial Arterial Calcification: A Significant and Independent Contributor of Peripheral Artery Disease.

Authors:  Cynthia St Hilaire
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-01-27       Impact factor: 8.311

3.  Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.

Authors:  Marc D Samsky; Robert J Mentz; Amanda Stebbins; Yuliya Lokhnygina; Aaron W Aday; Neha J Pagidipati; W Schuyler Jones; Brian G Katona; Manesh R Patel; Rury R Holman; Adrian F Hernandez; Jorge Antonio Gutierrez
Journal:  Atherosclerosis       Date:  2021-11-01       Impact factor: 5.162

Review 4.  Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy.

Authors:  Jonathan Golledge; Malindu E Fernando; David G Armstrong
Journal:  Drugs       Date:  2022-08-12       Impact factor: 11.431

Review 5.  Sex as a Key Determinant of Peripheral Artery Disease: Epidemiology, Differential Outcomes, and Proposed Biological Mechanisms.

Authors:  Amanda Morrison; Aaron W Aday
Journal:  Can J Cardiol       Date:  2022-02-26       Impact factor: 6.614

6.  Meta-Analysis of Intensive Lipid-Lowering Therapy in Patients With Polyvascular Disease.

Authors:  Mohammad Alkhalil; Michał Kuzemczak; Nicholas Whitehead; Charalampos Kavvouras; Vladimír Džavík
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

7.  The Proinflammatory Soluble CD40 Ligand Is Associated with the Systemic Extent of Stable Atherosclerosis.

Authors:  Tiago Pereira-da-Silva; Patrícia Napoleão; Teresa Pinheiro; Mafalda Selas; Filipa Silva; Rui Cruz Ferreira; Miguel Mota Carmo
Journal:  Medicina (Kaunas)       Date:  2021-01-04       Impact factor: 2.430

Review 8.  Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol.

Authors:  Ahmed Abdalwahab; Ayman Al-Atta; Azfar Zaman; Mohammad Alkhalil
Journal:  World J Cardiol       Date:  2021-09-26

9.  Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease.

Authors:  Rutao Wang; Scot Garg; Chao Gao; Hideyuki Kawashima; Masafumi Ono; Hironori Hara; Robert-Jan van Geuns; Marie-Claude Morice; Piroze M Davierwala; Arie Pieter Kappetein; David R Holmes; William Wijns; Ling Tao; Yoshinobu Onuma; Patrick W Serruys
Journal:  Clin Res Cardiol       Date:  2021-08-25       Impact factor: 5.460

10.  Epidemiology of Peripheral Artery Disease and Polyvascular Disease.

Authors:  Aaron W Aday; Kunihiro Matsushita
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.